Atormac
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 4227  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (409 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this Article
   References

 Article Access Statistics
    Viewed2208    
    Printed17    
    Emailed0    
    PDF Downloaded23    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
CORRESPONDENCES
Year : 2018  |  Volume : 66  |  Issue : 2  |  Page : 582-583

Author's Reply: Standard of care for Duchenne muscular dystrophy in children


Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India

Date of Web Publication15-Mar-2018

Correspondence Address:
Dr. A Nalini
Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.227273

Rights and Permissions



How to cite this article:
Nalini A. Author's Reply: Standard of care for Duchenne muscular dystrophy in children. Neurol India 2018;66:582-3

How to cite this URL:
Nalini A. Author's Reply: Standard of care for Duchenne muscular dystrophy in children. Neurol India [serial online] 2018 [cited 2019 Aug 25];66:582-3. Available from: http://www.neurologyindia.com/text.asp?2018/66/2/582/227273




In our article, we have clearly compared the outcome among those who have received steroids vs. those who have not.[1] Further, treatment with steroids is a standard of care for children with Duchenne muscular dystrophy (DMD) for the last few decades and it would be impossible to perform a natural history study on drug naïve children. There are earlier studies on the natural history where both groups have been included for outcome studies. In the study by Roberto et al.,[2] 174 male patients with DMD, ranging from 9 to 35 years, with an average age at the initial visit of almost 21 years were studied. 72 subjects were on steroids, 22 subjects were not on steroids, and the steroid treatment status of 80 subjects was unknown. In another study by Bushby et al.,[3] the tests conducted best demonstrated differences in steroid-treated and naive populations from the youngest ages into the mid-teens, and were most sensitive to 1-year changes between 7–9 and 10–12 years of age for standing from supine, and 7–9, 10– 12 and 13–18 years for stair climb and 10-m run/walk.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Singh RJ, Manjunath M, Preethish-Kumar V, Polavarapu K, Vengalil S, Thomas PT, et al. Natural history of a cohort of Duchenne muscular dystrophy children seen between 1998 and 2014: An observational study from South India. Neurol India 2018;66:77-82.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Roberto R, Fritz A, Hagar Y, Boice B, Skalsky A, Hwang H, et al. The natural history of cardiac and pulmonary function decline in patients with Duchenne muscular dystrophy. Spine 2011;36:E1009-E1017.  Back to cited text no. 2
    
3.
Bushby K, Connor E. Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. Clinical investigation 2011;1:1217-35.  Back to cited text no. 3
    




 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow